Omicron is bad but the global response is worse.

Nature ; 600(7888): 190, 2021 12.

Article in English | MEDLINE | ID: covidwho-1565700

Subject(s)

COVID-19 Vaccines/supply & distribution; COVID-19/epidemiology; COVID-19/prevention & control; Health Status Disparities; Healthcare Disparities/ethics; Healthcare Disparities/statistics & numerical data; SARS-CoV-2; COVID-19/transmission; COVID-19/virology; Developed Countries; Developing Countries; European Union; Global Health/statistics & numerical data; Global Health/trends; Healthcare Disparities/trends; Humans; Information Dissemination; International Cooperation/legislation & jurisprudence; Pandemics/prevention & control; Pandemics/statistics & numerical data; Patents as Topic/ethics; Patents as Topic/legislation & jurisprudence; SARS-CoV-2/isolation & purification; South Africa/epidemiology; Travel/statistics & numerical data; Uncertainty; Vulnerable Populations; World Health Organization

Keywords

Intellectual-property rights; Policy; SARS-CoV-2; Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Health Status Disparities / Healthcare Disparities / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational study / Randomized controlled trials Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Africa Language: English Journal: Nature Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google